Press "Enter" to skip to content

New patent expiration for Allergan Sales drug PYLERA

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Allergan Sales drug PYLERA

Annual Drug Patent Expirations for PYLERA
Annual Drug Patent Expirations for PYLERA

Pylera is a drug marketed by Allergan Sales Llc and is included in one NDA. It is available from one supplier. There is one patent protecting this drug and one Paragraph IV challenge.

This drug has thirty patent family members in twenty-four countries.

The generic ingredient in PYLERA is bismuth subcitrate potassium; metronidazole; tetracycline. One supplier is listed for this compound. Additional details are available on the bismuth subcitrate potassium; metronidazole; tetracycline profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent expiration for Allergan Sales drug PYLERA
Do NOT follow this link or you will be banned from the site!